TREM2 variants are the second genetic risk factor for AD, behind apolipoprotein E4 (ApoE4), demonstrating the key role of the innate immunity in AD pathogenesis (Basha et al., 2023). The gene discussed is APOE; the disease is Alzheimer disease.